01—Abstract
Summary
Summary of the 10-K filed February 18, 2021. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. (formerly Anthem Inc.) reported strong operational and financial performance for the fiscal year ending December 31, 2020.
The company demonstrated robust revenue growth, driven by expansion in its Government Business segment (Medicare and Medicaid) and the successful integration of its Pharmacy Benefit Manager (PBM) services through IngenioRx. Despite the challenges posed by the COVID-19 pandemic, Elevance Health maintained a solid membership base, particularly in its government programs, benefiting from increased eligibility and utilization. The company's strategic diversification into integrated health services, highlighted by the acquisition of Beacon Health Options, is progressing well and is expected to contribute to long-term growth.
Financially, the company reported total revenues of $121.9 billiona, with net income of $4.6 billion. While facing increased COVID-19 related expenses, including testing and treatment, the company managed its benefit expense ratio effectively, partly due to reduced utilization of non-COVID-19 services. Elevance Health also actively managed its capital through share repurchases and dividend payments, reflecting a commitment to shareholder value.
The company's balance sheet remains strong, with significant cash and investments, supporting its ongoing operations and strategic initiatives. Investors should note the ongoing regulatory landscape and the company's proactive approach to managing evolving healthcare policies and market dynamics.
02—Key points
Key Highlights
- Total revenues increased by 16.9% to $121.9 billion in 2020, driven by membership growth in Government Business and the IngenioRx PBM segment.
- Net income was $4.6 billion for 2020, a slight decrease from 2019, impacted by COVID-19 related expenses and business optimization initiatives, but offset by strong performance in Government and IngenioRx segments.
- Medical membership grew by 4.7% to 42.9 million, with notable increases in Medicaid and Medicare, signaling strength in government-sponsored programs.
- Acquisition of Beacon Health Options in February 2020 diversifies the company's offerings into behavioral health services, aligning with its strategy for integrated care.
- Operating cash flow significantly increased to $10.7 billion in 2020, demonstrating strong cash generation capabilities.
- The company repurchased $2.7 billion of common stock and paid $0.95 billion in dividends in 2020, returning capital to shareholders.
- Anthem's investment portfolio remains substantial, with cash, cash equivalents, and investments totaling $31.3 billion as of December 31, 2020.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2020, Elevance Health, Inc. kept $0.04.
- Revenue$121.87B100.0%
- Cost of revenue−$8.95B7.3%
- Gross profit$112.91B92.7%
- Operating costs−$106.55B87.4%
- Operating income$6.36B5.2%
- Interest, other & tax−$1.79B1.5%
- Net income$4.57B3.8%
Where FY2020 revenue went
$121.87B- Other operating costs: $89.10B, 73% of revenue
- SG&A: $17.45B, 14% of revenue
- Net income: $4.57B, 3.8% of revenue
- Cost of revenue: $8.95B, 7.3% of revenue
- Interest, other & tax: $1.79B, 1.5% of revenue
Kept 3.8% as net incomeNet income $4.57B · 3.8%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2020filed February 18, 2021Financial Statements
FY2020 against FY2019
| Line item | FY2020FY2019 | Change |
|---|---|---|
| Revenue | $121.87B$104.21B | +16.9% |
| Cost of Revenue | $8.95B$1.99B | +349.4% |
| Gross Profit | $112.91B$102.22B | +10.5% |
| SG&A Expenses | $17.45B$13.36B | +30.6% |
| Operating Income | $6.36B$6.00B | +6.0% |
| Interest Expense | $784.00M$746.00M | +5.1% |
| Net Income | $4.57B$4.81B | −4.9% |
| EPS (Basic) | $18.23$18.81 | −3.1% |
| EPS (Diluted) | $17.98$18.47 | −2.7% |
| Shares Outstanding (Basic) | 250.80M255.50M | −1.8% |
| Shares Outstanding (Diluted) | 254.30M260.30M | −2.3% |
05—Questions
Frequently Asked Questions
What was Elevance Health's (Anthem's) total revenue for the fiscal year 2020?
Elevance Health reported total revenues of $121.9 billion for the fiscal year ended December 31, 2020.
How did the COVID-19 pandemic impact the company's financial performance in 2020?
The COVID-19 pandemic impacted the company by increasing expenses related to testing, treatment, and expanded benefit coverage. However, this was partially offset by reduced utilization of non-COVID-19 health services. Overall, the company stated that the pandemic did not have a material adverse effect on its reported results in 2020, but acknowledges potential future impacts.
What is the significance of the IngenioRx segment?
IngenioRx is Elevance Health's Pharmacy Benefit Manager (PBM) business, which began operations in Q2 2019. Its growth and integration are significant drivers of revenue and represent a strategic expansion into managing pharmacy benefits for both affiliated health plans and external customers.
What were the key strategic acquisitions or developments in 2020?
A significant development in 2020 was the acquisition of Beacon Health Options, Inc., the largest independently held behavioral health organization in the country. This acquisition aligns with the company's strategy to diversify into health services and provide integrated care solutions.
06—Continue